127 related articles for article (PubMed ID: 37605570)
21. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
22. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma.
Yu L; Shao X; Huo L; Zhang T
Med Sci Monit; 2020 Sep; 26():e924187. PubMed ID: 32879299
[TBL] [Abstract][Full Text] [Related]
24. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
[TBL] [Abstract][Full Text] [Related]
25. METTL3/
Xiong J; Lian W; Zhao R; Gao K
Onco Targets Ther; 2024; 17():85-97. PubMed ID: 38348427
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma.
Lei X; Yang S; Yang Y; Zhang J; Wang Y; Cao M
Am J Transl Res; 2019; 11(10):6569-6576. PubMed ID: 31737208
[TBL] [Abstract][Full Text] [Related]
27. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
He T; Xia H; Chen B; Duan Z; Huang C
Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
[TBL] [Abstract][Full Text] [Related]
28. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis.
Li Q; Dai Z; Xia C; Jin L; Chen X
Mol Cell Biochem; 2020 Jul; 470(1-2):165-174. PubMed ID: 32468237
[TBL] [Abstract][Full Text] [Related]
29. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
30. METTL3-mediated m6A modification of has_circ_0007905 promotes age-related cataract progression through miR-6749-3p/EIF4EBP1.
Li R; Zhu H; Li Q; Tang J; Jin Y; Cui H
PeerJ; 2023; 11():e14863. PubMed ID: 36908822
[TBL] [Abstract][Full Text] [Related]
31. N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.
Zhang C; Cui Y
Biol Chem; 2024 Mar; 405(3):217-228. PubMed ID: 37694982
[TBL] [Abstract][Full Text] [Related]
32. LncRNA metastasis-associated lung adenocarcinoma transcript-1 promotes osteogenic differentiation of bone marrow stem cells and inhibits osteoclastic differentiation of Mø in osteoporosis via the miR-124-3p/IGF2BP1/Wnt/β-catenin axis.
Li X
J Tissue Eng Regen Med; 2022 Mar; 16(3):311-329. PubMed ID: 34962086
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract][Full Text] [Related]
34. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.
Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J
Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246
[TBL] [Abstract][Full Text] [Related]
35. METTL3-mediated LINC00657 promotes osteogenic differentiation of mesenchymal stem cells via miR-144-3p/BMPR1B axis.
Peng J; Zhan Y; Zong Y
Cell Tissue Res; 2022 May; 388(2):301-312. PubMed ID: 35192037
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis.
Geng Y; Chen P; Zhang L; Li X; Song C; Wei X; Gong H
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):133-140. PubMed ID: 37329534
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.
Zha X; Xi X; Fan X; Ma M; Zhang Y; Yang Y
Aging (Albany NY); 2020 May; 12(9):8137-8150. PubMed ID: 32365051
[TBL] [Abstract][Full Text] [Related]
39. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
[TBL] [Abstract][Full Text] [Related]
40. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
Chen L; Yao H; Wang K; Liu X
J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]